TRAF7-Mutated Myxoid and Spindle Cell Mesenchymal Tumor Occurring in a Pediatric Patient in the Post-Transplant Setting: Expanding the Spectrum of TRAF7-Mutated Tumors

IF 2.3 2区 医学 Q2 GENETICS & HEREDITY
Stephanie Torres, Zachary High, Qian Wang, Clinton Piper, Erika Friehling, Brian Feingold, Ivy John, Marcus Malek, Armando Ganoza, John M. Skaugen, Catherine K. Gestrich
{"title":"TRAF7-Mutated Myxoid and Spindle Cell Mesenchymal Tumor Occurring in a Pediatric Patient in the Post-Transplant Setting: Expanding the Spectrum of TRAF7-Mutated Tumors","authors":"Stephanie Torres,&nbsp;Zachary High,&nbsp;Qian Wang,&nbsp;Clinton Piper,&nbsp;Erika Friehling,&nbsp;Brian Feingold,&nbsp;Ivy John,&nbsp;Marcus Malek,&nbsp;Armando Ganoza,&nbsp;John M. Skaugen,&nbsp;Catherine K. Gestrich","doi":"10.1002/gcc.70092","DOIUrl":null,"url":null,"abstract":"<div>\n \n <p><i>TRAF7</i> mutations have been reported in many tumor types, including subsets of meningiomas, mesothelioma, intraneural perineuriomas, and rare cases of aggressive fibromyxoid spindle cell tumors in adults. We expand the spectrum of <i>TRAF7</i>-mutated tumors by reporting a case of a <i>TRAF7</i>-mutated myxoid and spindle cell mesenchymal tumor in a 13-year-old female with a history of a heart and renal transplant. Histopathologic examination demonstrated hypocellular areas composed of bland spindle cells in a myxoid matrix and hypercellular areas with significant pleomorphism and up to 13 mitotic figures per 10 high-power fields. The spindle cells were positive for CD34 and negative for smooth muscle actin (SMA) and S100. Whole exome sequencing identified a <i>TRAF7</i> p.S561R mutation. Methylation profiling illustrated that the tumor did not embed within a distinct tumor group. The tumor was resected, and the patient remains stable at 7 months follow-up. This report is the first known case of a <i>TRAF7</i>-mutated myxoid and spindle cell tumor in a pediatric patient.</p>\n </div>","PeriodicalId":12700,"journal":{"name":"Genes, Chromosomes & Cancer","volume":"64 11","pages":""},"PeriodicalIF":2.3000,"publicationDate":"2025-11-12","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Genes, Chromosomes & Cancer","FirstCategoryId":"3","ListUrlMain":"https://onlinelibrary.wiley.com/doi/10.1002/gcc.70092","RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q2","JCRName":"GENETICS & HEREDITY","Score":null,"Total":0}
引用次数: 0

Abstract

TRAF7 mutations have been reported in many tumor types, including subsets of meningiomas, mesothelioma, intraneural perineuriomas, and rare cases of aggressive fibromyxoid spindle cell tumors in adults. We expand the spectrum of TRAF7-mutated tumors by reporting a case of a TRAF7-mutated myxoid and spindle cell mesenchymal tumor in a 13-year-old female with a history of a heart and renal transplant. Histopathologic examination demonstrated hypocellular areas composed of bland spindle cells in a myxoid matrix and hypercellular areas with significant pleomorphism and up to 13 mitotic figures per 10 high-power fields. The spindle cells were positive for CD34 and negative for smooth muscle actin (SMA) and S100. Whole exome sequencing identified a TRAF7 p.S561R mutation. Methylation profiling illustrated that the tumor did not embed within a distinct tumor group. The tumor was resected, and the patient remains stable at 7 months follow-up. This report is the first known case of a TRAF7-mutated myxoid and spindle cell tumor in a pediatric patient.

儿童移植后发生traf7突变的黏液样和梭形细胞间质肿瘤:扩大traf7突变肿瘤的范围。
据报道,TRAF7突变存在于许多肿瘤类型中,包括脑膜瘤、间皮瘤、神经内会阴瘤亚群,以及罕见的成人侵袭性纤维黏液样梭形细胞瘤。我们扩大了traf7突变肿瘤的范围,报告了一例traf7突变的黏液样和梭形细胞间充质肿瘤,患者为13岁女性,有心脏和肾脏移植史。组织病理学检查显示黏液样基质中淡色梭形细胞组成的低细胞区和具有明显多形性的高细胞区,每10个高倍视场高达13个有丝分裂象。梭形细胞CD34阳性,平滑肌肌动蛋白(SMA)和S100阴性。全外显子组测序鉴定出TRAF7 p.S561R突变。甲基化分析表明,肿瘤没有嵌入一个独特的肿瘤组。手术切除肿瘤,随访7个月病情稳定。本报告是第一例已知的traf7突变的黏液样和梭形细胞肿瘤的儿科患者。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 求助全文
来源期刊
Genes, Chromosomes & Cancer
Genes, Chromosomes & Cancer 医学-遗传学
CiteScore
7.00
自引率
8.10%
发文量
94
审稿时长
4-8 weeks
期刊介绍: Genes, Chromosomes & Cancer will offer rapid publication of original full-length research articles, perspectives, reviews and letters to the editors on genetic analysis as related to the study of neoplasia. The main scope of the journal is to communicate new insights into the etiology and/or pathogenesis of neoplasia, as well as molecular and cellular findings of relevance for the management of cancer patients. While preference will be given to research utilizing analytical and functional approaches, descriptive studies and case reports will also be welcomed when they offer insights regarding basic biological mechanisms or the clinical management of neoplastic disorders.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:604180095
Book学术官方微信
小红书